Xue Guan

966 total citations · 1 hit paper
29 papers, 757 citations indexed

About

Xue Guan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xue Guan has authored 29 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Xue Guan's work include Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (6 papers). Xue Guan is often cited by papers focused on Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers) and Cancer-related molecular mechanisms research (6 papers). Xue Guan collaborates with scholars based in China, Japan and United States. Xue Guan's co-authors include Yang Zhao, Zhi‐Hong Zong, Shuo Chen, Lili Wang, Yao Liu, Yuping Du, Yao Liu, Yao Liu, Kaixuan Sun and Min Zhang and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Xue Guan

26 papers receiving 752 citations

Hit Papers

Lactate accumulation induces H4K12la to activate super-en... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Guan China 17 610 493 67 64 50 29 757
Weimin Ren China 15 317 0.5× 244 0.5× 75 1.1× 51 0.8× 105 2.1× 23 543
Shao-Guang Sun China 12 509 0.8× 347 0.7× 49 0.7× 81 1.3× 26 0.5× 28 653
Floriana Maria Farina Italy 12 434 0.7× 295 0.6× 55 0.8× 99 1.5× 37 0.7× 16 593
Liwen Zhang China 12 311 0.5× 257 0.5× 48 0.7× 69 1.1× 83 1.7× 25 509

Countries citing papers authored by Xue Guan

Since Specialization
Citations

This map shows the geographic impact of Xue Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Guan more than expected).

Fields of papers citing papers by Xue Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Guan. The network helps show where Xue Guan may publish in the future.

Co-authorship network of co-authors of Xue Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Guan. A scholar is included among the top collaborators of Xue Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Guan. Xue Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guan, Xue, et al.. (2025). pH-responsive 2D niobium carbide nanosheets for targeted circPUM1 siRNA delivery in ovarian cancer therapy. Materials Today Bio. 35. 102314–102314.
2.
Tao, Ye, Weiyu Liu, Xue Guan, et al.. (2025). Integrated horizontal convective PCR system for clinical diagnostics. Science Advances. 11(32). eadx8434–eadx8434. 2 indexed citations
3.
Han, Yang, Jianqi Li, Qinghua Wu, et al.. (2025). piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer. npj Precision Oncology. 9(1). 65–65. 1 indexed citations
4.
Chen, Shuo, Xue Guan, Xi Chen, et al.. (2025). Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer. Molecular Cancer. 24(1). 83–83. 18 indexed citations breakdown →
5.
Zhao, Yajie, Tianwen Gao, Xue Guan, et al.. (2025). Chronic intermittent cold stress-induced lipophagy promotes foamy macrophage susceptibility to ferroptosis and exacerbates atherosclerosis. Free Radical Biology and Medicine. 242. 636–653.
6.
Li, Manman, Dengfeng Zhang, Ying Zhao, et al.. (2023). Vascular Electrical Stimulation with Wireless, Battery‐Free, and Fully Implantable Features Reduces Atherosclerotic Plaque Formation Through Sirt1‐Mediated Autophagy. Small. 19(40). e2300584–e2300584. 6 indexed citations
7.
Zhang, Dongmei, Yu Pan, Xiuli Wang, et al.. (2021). Overexpression of PELP1 in Lung Adenocarcinoma Promoted E2 Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients. Pathology & Oncology Research. 27. 582443–582443. 4 indexed citations
8.
Yu, Jingwei, Wenchen Gong, Liping Su, et al.. (2021). An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy. Frontiers in Oncology. 11. 708784–708784. 8 indexed citations
9.
Du, Yuping, Xin Liu, Shuo Chen, et al.. (2021). CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis. Reproductive Biology and Endocrinology. 19(1). 176–176. 24 indexed citations
10.
Liu, Youbin, et al.. (2020). Combination of LCZ696 and ACEI further improves heart failure and myocardial fibrosis after acute myocardial infarction in mice. Biomedicine & Pharmacotherapy. 133. 110824–110824. 19 indexed citations
11.
Guan, Xue, Zhi‐Hong Zong, Yao Liu, et al.. (2019). circPUM1 Promotes Tumorigenesis and Progression of Ovarian Cancer by Sponging miR-615-5p and miR-6753-5p. Molecular Therapy — Nucleic Acids. 18. 882–892. 98 indexed citations
12.
Zong, Zhi‐Hong, Yuping Du, Xue Guan, Shuo Chen, & Yang Zhao. (2019). CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. Journal of Experimental & Clinical Cancer Research. 38(1). 437–437. 111 indexed citations
13.
Zhang, Min, Xin Wei, Yang Yu, et al.. (2019). Programmed death-ligand 1 triggers PASMCs pyroptosis and pulmonary vascular fibrosis in pulmonary hypertension. Journal of Molecular and Cellular Cardiology. 138. 23–33. 67 indexed citations
14.
Li, Yongguo, K. Zhang, Xi Zhang, et al.. (2019). Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. Journal of Cancer. 11(1). 142–152. 10 indexed citations
15.
Guan, Xue, Shuo Chen, Yao Liu, et al.. (2018). PUM1 promotes ovarian cancer proliferation, migration and invasion. Biochemical and Biophysical Research Communications. 497(1). 313–318. 31 indexed citations
16.
Chen, Shuo, Lili Wang, Kaixuan Sun, et al.. (2018). LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway. Cellular Physiology and Biochemistry. 47(4). 1578–1588. 41 indexed citations
17.
Chen, Shuo, Kaixuan Sun, Yao Liu, et al.. (2018). LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 3013–3021. 49 indexed citations
18.
Chen, Shuo, Xue Guan, Lili Wang, et al.. (2017). Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4. Gene. 635. 3–8. 22 indexed citations
19.
Liu, Yao, Zhi‐Hong Zong, Xue Guan, Lili Wang, & Yang Zhao. (2017). The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression. Gene. 633. 42–47. 30 indexed citations
20.
Guan, Xue, Zhi‐Hong Zong, Shuo Chen, et al.. (2017). The role of miR-372 in ovarian carcinoma cell proliferation. Gene. 624. 14–20. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026